rs1028149417
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_001105659.2(LRRIQ3):c.1392A>C(p.Lys464Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000621 in 1,611,254 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001105659.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRRIQ3 | ENST00000354431.9 | c.1392A>C | p.Lys464Asn | missense_variant | Exon 7 of 8 | 5 | NM_001105659.2 | ENSP00000346414.4 | ||
LRRIQ3 | ENST00000395089.5 | c.1392A>C | p.Lys464Asn | missense_variant | Exon 6 of 7 | 5 | ENSP00000378524.1 | |||
LRRIQ3 | ENST00000417067.5 | c.131-14570A>C | intron_variant | Intron 1 of 1 | 2 | ENSP00000390376.1 | ||||
LRRIQ3 | ENST00000415760.5 | n.*2703+152A>C | intron_variant | Intron 9 of 9 | 2 | ENSP00000415319.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152148Hom.: 0 Cov.: 32 show subpopulations
GnomAD4 exome AF: 0.00000548 AC: 8AN: 1459106Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 725794 show subpopulations
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152148Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74330 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1392A>C (p.K464N) alteration is located in exon 7 (coding exon 6) of the LRRIQ3 gene. This alteration results from a A to C substitution at nucleotide position 1392, causing the lysine (K) at amino acid position 464 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at